Dario Amodei

Doing the whole thing from end to end.

And part of that involves proposing experiments, coming up with new techniques.

I have this section where I say, look, a lot of the progress in biology has been driven by this relatively small number of insights that lets us measure or get at or intervene in the stuff that's really small.

You look at a lot of these techniques, they're invented very much as a matter of serendipity, right?

CRISPR, which is one of these gene editing technologies, was invented because someone went to a lecture on the bacterial immune system and connected that to the work they were doing on gene therapy.

And that connection could have been made 30 years ago.

And so

The thought is, you know, could AI accelerate all of this?

And could we really cure cancer?

Could we really cure Alzheimer's disease?

Could we really cure heart disease?

And, you know, more subtly, some of the more psychological afflictions that people have, you know,

Depression, bipolar, you know, could we do something about these to the extent that they're biologically based, which, you know, I think they are at least in part.

And, you know, I go through this argument here.

Well, how fast could it go?

Right.

If we have these intelligences out there who could do just about anything.

A country, have 100 million of them.

Each a little, trained a little different or trying a different problem.

There's benefit in diversification and trying things a little differently, but yes.